NO20023464D0 - Sammensetning for intestinal avlevering - Google Patents

Sammensetning for intestinal avlevering

Info

Publication number
NO20023464D0
NO20023464D0 NO20023464A NO20023464A NO20023464D0 NO 20023464 D0 NO20023464 D0 NO 20023464D0 NO 20023464 A NO20023464 A NO 20023464A NO 20023464 A NO20023464 A NO 20023464A NO 20023464 D0 NO20023464 D0 NO 20023464D0
Authority
NO
Norway
Prior art keywords
composition
active agent
physiologically active
intestinal delivery
uptake
Prior art date
Application number
NO20023464A
Other languages
English (en)
Other versions
NO20023464L (no
NO326525B1 (no
Inventor
Grant William Vandenberg
Original Assignee
Aqua Solution Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aqua Solution Inc filed Critical Aqua Solution Inc
Publication of NO20023464D0 publication Critical patent/NO20023464D0/no
Publication of NO20023464L publication Critical patent/NO20023464L/no
Publication of NO326525B1 publication Critical patent/NO326525B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/105—Aliphatic or alicyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/168—Steroids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/184—Hormones
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/24—Compounds of alkaline earth metals, e.g. magnesium
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81—Aquaculture, e.g. of fish
    • Y02A40/818—Alternative feeds for fish, e.g. in aquacultures
NO20023464A 2000-01-27 2002-07-19 Sammensetning for intestinal avlevering og anvendelse av slike for fremstilling av medikament for behandling av intestinale infeksjoner. NO326525B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17831800P 2000-01-27 2000-01-27
PCT/CA2001/000073 WO2001054514A1 (en) 2000-01-27 2001-01-25 Composition for intestinal delivery

Publications (3)

Publication Number Publication Date
NO20023464D0 true NO20023464D0 (no) 2002-07-19
NO20023464L NO20023464L (no) 2002-09-24
NO326525B1 NO326525B1 (no) 2008-12-29

Family

ID=22652068

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023464A NO326525B1 (no) 2000-01-27 2002-07-19 Sammensetning for intestinal avlevering og anvendelse av slike for fremstilling av medikament for behandling av intestinale infeksjoner.

Country Status (13)

Country Link
EP (1) EP1250056B1 (no)
JP (1) JP2003520862A (no)
KR (1) KR20030009344A (no)
CN (1) CN100366295C (no)
AT (1) ATE337712T1 (no)
AU (1) AU2990401A (no)
CA (1) CA2396711A1 (no)
DE (1) DE60122672T2 (no)
IL (1) IL150818A0 (no)
MX (1) MXPA02007202A (no)
NO (1) NO326525B1 (no)
NZ (1) NZ520238A (no)
WO (1) WO2001054514A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10105306A1 (de) * 2001-02-02 2002-08-22 Nutrinova Gmbh Futtermittel für die Nutztieraufzucht enthaltend Sorbinsäure und Enzyme
DE10105347A1 (de) * 2001-02-05 2002-08-22 Nutrinova Gmbh Sorbinsäurepräparat enthaltend Probiotika als Futtermittelzusatz in der Nutztieraufzucht
DE10110431A1 (de) * 2001-03-05 2002-09-19 Nutrinova Gmbh Bacteriocinhaltiges Sorbinsäurepräparat als Futtermittelzusatz in der Nutztieraufzucht
ITFI20020043A1 (it) * 2002-03-08 2003-09-08 Fernando Cantini Un prodotto lipidico a base di monogliceridi e digliceridi dell'acidooleico,trigliceridi randomizzati e glicerolo,per alimentazione animale
AU2003218576A1 (en) * 2002-04-08 2003-10-27 Peros Systemes Technologies Inc. Composition for modulating a physiological reaction or inducing an immune response
GB2399752A (en) * 2003-03-26 2004-09-29 Micap Plc Pharmaceutical composition comprising a fungal cell or cell fragment as adjuvant
WO2005084704A1 (en) * 2004-03-02 2005-09-15 Peros Systems Technologies Inc. Digestive bypass composition for arthropod and uses thereof
US20050282756A1 (en) 2004-06-18 2005-12-22 Mehta Nozer M Oral delivery of peptide pharmaceutical compositions
EP2417986A1 (en) * 2004-11-22 2012-02-15 Anadis Ltd. Bioactive compositions
DE102005010288A1 (de) * 2005-03-02 2006-09-07 Riemser Arzneimittel Ag Pharmazeutisches, oral applizierbares Präparat zur Behandlung von Fischen, Herstellungsverfahren für dieses und seine Verwendung
US8426466B2 (en) 2006-05-22 2013-04-23 Nexus Pharma, Inc. Compositions and methods for enhancing active agent absorption
EP2150243A4 (en) * 2007-05-21 2013-08-21 Nexus Pharma Inc COMPOSITIONS AND METHODS FOR REINFORCED ACTIVE SUBSTANCE ABSORPTION
US20090111736A1 (en) * 2007-10-29 2009-04-30 Sri International Orally-Absorbed Solid Dose Formulation for Vancomycin
KR101045516B1 (ko) * 2008-10-06 2011-06-30 부산대학교 산학협력단 식물 세포벽을 구성하는 다양한 다당류를 분해하는 효소를 생산하는 클렙시엘라 속 미생물
RU2449779C1 (ru) * 2010-12-20 2012-05-10 Государственное образовательное учреждение высшего профессионального образования "БАШКИРСКИЙ ГОСУДАРСТВЕННЫЙ МЕДИЦИНСКИЙ УНИВЕРСИТЕТ ФЕДЕРАЛЬНОГО АГЕНТСТВА ПО ЗДРАВООХРАНЕНИЮ И СОЦИАЛЬНОМУ РАЗВИТИЮ" Драже с оксиметилурацилом и нетилмицином для лечения инфекционных заболеваний кишечника
CN102727521B (zh) * 2012-06-13 2013-07-24 辽宁王牌速效制药有限公司 庆大霉素碳酸铋胶囊内容物肠道释放微丸的制备方法
CN107568117B (zh) * 2017-09-15 2020-10-13 广东海大畜牧兽医研究院有限公司 一种鱼类免疫试剂
WO2019199238A1 (en) * 2018-04-09 2019-10-17 Vet Products Research And Innovation Center Company Limited Inorganic mineral entrapped in nanoparticle production method thereof
CN112826836A (zh) * 2021-01-08 2021-05-25 深圳未知君生物科技有限公司 一种粪菌口服制剂及其制备方法
CN113234641B (zh) * 2021-06-21 2022-07-19 西北民族大学 一株耐低温、产蛋白酶的芽孢杆菌s77及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993011799A1 (en) * 1991-12-18 1993-06-24 Pfizer Inc. Soybean protein or hydrolyzates in pharmaceutical compositions to protect bioactive peptides from enzymatic inactivation
AU1808897A (en) * 1995-12-13 1997-07-03 Dullatur Limited A calcitonin preparation
EP0923312A1 (en) * 1996-04-29 1999-06-23 K.U. Leuven Research & Development Oral delivery form having a high absorption efficiency and method for making same

Also Published As

Publication number Publication date
DE60122672D1 (de) 2006-10-12
WO2001054514A1 (en) 2001-08-02
MXPA02007202A (es) 2003-09-22
DE60122672T2 (de) 2007-08-30
CN1406112A (zh) 2003-03-26
ATE337712T1 (de) 2006-09-15
CA2396711A1 (en) 2001-08-02
KR20030009344A (ko) 2003-01-29
NO20023464L (no) 2002-09-24
EP1250056B1 (en) 2006-08-30
EP1250056A1 (en) 2002-10-23
CN100366295C (zh) 2008-02-06
NZ520238A (en) 2004-04-30
JP2003520862A (ja) 2003-07-08
NO326525B1 (no) 2008-12-29
IL150818A0 (en) 2003-02-12
AU2990401A (en) 2001-08-07

Similar Documents

Publication Publication Date Title
NO20023464L (no) Sammensetning for intestinal avlevering
MY124714A (en) Enzyme treatment
MXPA05006940A (es) Formulaciones terapeuticas para el tratamiento de enfermedades relacionadas con beta - amiloide.
GEP20053602B (en) Aripiprazole for Oral Administration
EP1317419A4 (en) CYANOPHENOXYCARBOXYLIC ACID COMPOUNDS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS
NZ709704A (en) Protein formulations and methods of making same
DE60220408D1 (de) Sequenzielles arzneimittelabgabesystem
BRPI0411924A (pt) métodos e dispositivos para oclusão de lúmens de corpo e/ou para fornecimento de agentes terapêuticos
HK1044477A1 (en) Medicament for treating diabetes
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
ATE355076T1 (de) Zusammensetzungen und methoden zur systemischen verabreichung von oralen impfstoffen und therapeutischen wirkstoffen
HK1060045A1 (en) Formulations comprising ibuprofen and diphenhydramine and the use thereof for the treatment of sleepdisturbances
WO2007049098A3 (en) Therapeutic formulations for the treatment of beta-amyloid related diseases
MY125356A (en) Moxifloxacin/sodium chloride formulation
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
IS6558A (is) Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni
HK1047707A1 (zh) (+)-曲馬朵、o-去甲曲馬朵或(+)-o-去甲曲馬朵、o-去甲-n-單-去甲-曲馬朵或(+)-o-去甲-n-單-去甲-曲馬朵治療尿失禁的用途
IT1314185B1 (it) Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi
BR0008443A (pt) Inibidores de aminotransferaseaminoácido-dependente de cadeia ramificada e seuuso no tratamento da retinopatia diabética
WO2001089317A3 (en) Dietary aids and methods of use thereof
WO2005056520A8 (en) Somatostatin receptor subtype 1 (sstr1) active compounds and their use in therapy
AR038414A1 (es) Composicion de distribucion in vivo
AU2001249267A1 (en) Methods and compositions for elucidating protein expression profiles in cells
BRPI0403271A (pt) composição de liberação in vivo
AU2003294834A1 (en) Anthranilic acid amide derivatives and their pharmaceutical use

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees